Global (United States, European Union and China) Sofosbuvir (CAS 1190307-88-0) Market Research Report 2019-2025


    Table of Contents

      1 Report Overview

      • 1.1 Research Scope
      • 1.2 Major Manufacturers Covered in This Report
      • 1.3 Market Segment by Type
        • 1.3.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type (2019-2025)
        • 1.3.2 ≥ 98% Purity
        • 1.3.3 < 98% Purity
      • 1.4 Market Segment by Application
        • 1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Application (2019-2025)
        • 1.4.2 400mg Tablets
        • 1.4.3 Others
      • 1.5 Study Objectives
      • 1.6 Years Considered

      2 Global Growth Trends

      • 2.1 Production and Capacity Analysis
        • 2.1.1 Global Sofosbuvir (CAS 1190307-88-0) Production Value 2014-2025
        • 2.1.2 Global Sofosbuvir (CAS 1190307-88-0) Production 2014-2025
        • 2.1.3 Global Sofosbuvir (CAS 1190307-88-0) Capacity 2014-2025
        • 2.1.4 Global Sofosbuvir (CAS 1190307-88-0) Marketing Pricing and Trends
      • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
        • 2.2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size CAGR of Key Regions
        • 2.2.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share of Key Regions
      • 2.3 Industry Trends
        • 2.3.1 Market Top Trends
        • 2.3.2 Market Drivers

      3 Market Share by Manufacturers

      • 3.1 Capacity and Production by Manufacturers
        • 3.1.1 Global Sofosbuvir (CAS 1190307-88-0) Capacity by Manufacturers
        • 3.1.2 Global Sofosbuvir (CAS 1190307-88-0) Production by Manufacturers
      • 3.2 Revenue by Manufacturers
        • 3.2.1 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2014-2019)
        • 3.2.2 Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2014-2019)
        • 3.2.3 Global Sofosbuvir (CAS 1190307-88-0) Market Concentration Ratio (CR5 and HHI)
      • 3.3 Sofosbuvir (CAS 1190307-88-0) Price by Manufacturers
      • 3.4 Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Plants/Factories Distribution and Area Served
      • 3.5 Date of Key Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
      • 3.6 Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Offered
      • 3.7 Mergers & Acquisitions, Expansion Plans

      4 Market Size by Type

      • 4.1 Production and Production Value for Each Type
        • 4.1.1 ≥ 98% Purity Production and Production Value (2014-2019)
        • 4.1.2 < 98% Purity Production and Production Value (2014-2019)
      • 4.2 Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Type
      • 4.3 Global Sofosbuvir (CAS 1190307-88-0) Production Value Market Share by Type
      • 4.4 Sofosbuvir (CAS 1190307-88-0) Ex-factory Price by Type

      5 Market Size by Application

      • 5.1 Overview
      • 5.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Application

      6 Production by Regions

      • 6.1 Global Sofosbuvir (CAS 1190307-88-0) Production (History Data) by Regions 2014-2019
      • 6.2 Global Sofosbuvir (CAS 1190307-88-0) Production Value (History Data) by Regions
      • 6.3 United States
        • 6.3.1 United States Sofosbuvir (CAS 1190307-88-0) Production Growth Rate 2014-2019
        • 6.3.2 United States Sofosbuvir (CAS 1190307-88-0) Production Value Growth Rate 2014-2019
        • 6.3.3 Key Players in United States
        • 6.3.4 United States Sofosbuvir (CAS 1190307-88-0) Import & Export
      • 6.4 European Union
        • 6.4.1 European Union Sofosbuvir (CAS 1190307-88-0) Production Growth Rate 2014-2019
        • 6.4.2 European Union Sofosbuvir (CAS 1190307-88-0) Production Value Growth Rate 2014-2019
        • 6.4.3 Key Players in European Union
        • 6.4.4 European Union Sofosbuvir (CAS 1190307-88-0) Import & Export
      • 6.5 China
        • 6.5.1 China Sofosbuvir (CAS 1190307-88-0) Production Growth Rate 2014-2019
        • 6.5.2 China Sofosbuvir (CAS 1190307-88-0) Production Value Growth Rate 2014-2019
        • 6.5.3 Key Players in China
        • 6.5.4 China Sofosbuvir (CAS 1190307-88-0) Import & Export
      • 6.6 Rest of World
        • 6.6.1 Japan
        • 6.6.2 Korea
        • 6.6.3 India
        • 6.6.4 Southeast Asia

      7 Sofosbuvir (CAS 1190307-88-0) Consumption by Regions

      • 7.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption (History Data) by Regions
      • 7.2 United States
        • 7.2.1 United States Sofosbuvir (CAS 1190307-88-0) Consumption by Type
        • 7.2.2 United States Sofosbuvir (CAS 1190307-88-0) Consumption by Application
      • 7.3 European Union
        • 7.3.1 European Union Sofosbuvir (CAS 1190307-88-0) Consumption by Type
        • 7.3.2 European Union Sofosbuvir (CAS 1190307-88-0) Consumption by Application
      • 7.4 China
        • 7.4.1 China Sofosbuvir (CAS 1190307-88-0) Consumption by Type
        • 7.4.2 China Sofosbuvir (CAS 1190307-88-0) Consumption by Application
      • 7.5 Rest of World
        • 7.5.1 Rest of World Sofosbuvir (CAS 1190307-88-0) Consumption by Type
        • 7.5.2 Rest of World Sofosbuvir (CAS 1190307-88-0) Consumption by Application
        • 7.5.1 Japan
        • 7.5.2 Korea
        • 7.5.3 India
        • 7.5.4 Southeast Asia

      8 Company Profiles

      • 8.1 Teva Pharmaceutical Industries Ltd
        • 8.1.1 Teva Pharmaceutical Industries Ltd Company Details
        • 8.1.2 Company Description and Business Overview
        • 8.1.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.1.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.1.5 Teva Pharmaceutical Industries Ltd Recent Development
      • 8.2 DONG BANG FUTURE TECH & LIFE CO., LTD
        • 8.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Company Details
        • 8.2.2 Company Description and Business Overview
        • 8.2.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.2.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
      • 8.3 NIFTY LABS PVT LTD
        • 8.3.1 NIFTY LABS PVT LTD Company Details
        • 8.3.2 Company Description and Business Overview
        • 8.3.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.3.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.3.5 NIFTY LABS PVT LTD Recent Development
      • 8.4 DEAFARMA
        • 8.4.1 DEAFARMA Company Details
        • 8.4.2 Company Description and Business Overview
        • 8.4.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.4.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.4.5 DEAFARMA Recent Development
      • 8.5 Anhui HaiKang Pharmaceutical Co. Ltd
        • 8.5.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Details
        • 8.5.2 Company Description and Business Overview
        • 8.5.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.5.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.5.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
      • 8.6 Haoyuan Chemexpress Co.Ltd
        • 8.6.1 Haoyuan Chemexpress Co.Ltd Company Details
        • 8.6.2 Company Description and Business Overview
        • 8.6.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.6.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.6.5 Haoyuan Chemexpress Co.Ltd Recent Development
      • 8.7 SMS Pharmaceuticals Limited
        • 8.7.1 SMS Pharmaceuticals Limited Company Details
        • 8.7.2 Company Description and Business Overview
        • 8.7.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.7.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.7.5 SMS Pharmaceuticals Limited Recent Development
      • 8.8 Beijing Kawin Technology Share-holding Co
        • 8.8.1 Beijing Kawin Technology Share-holding Co Company Details
        • 8.8.2 Company Description and Business Overview
        • 8.8.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.8.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.8.5 Beijing Kawin Technology Share-holding Co Recent Development
      • 8.9 Manus Aktteva Biopharma LLP
        • 8.9.1 Manus Aktteva Biopharma LLP Company Details
        • 8.9.2 Company Description and Business Overview
        • 8.9.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.9.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.9.5 Manus Aktteva Biopharma LLP Recent Development
      • 8.10 Hangzhou Longshine Bio-Tech Co
        • 8.10.1 Hangzhou Longshine Bio-Tech Co Company Details
        • 8.10.2 Company Description and Business Overview
        • 8.10.3 Production and Revenue of Sofosbuvir (CAS 1190307-88-0)
        • 8.10.4 Sofosbuvir (CAS 1190307-88-0) Product Introduction
        • 8.10.5 Hangzhou Longshine Bio-Tech Co Recent Development
      • 8.11 Tecoland
      • 8.12 Sinobright Pharmaceutical Company Limited

      9 Market Forecast

      • 9.1 Global Market Size Forecast
        • 9.1.1 Global Sofosbuvir (CAS 1190307-88-0) Capacity, Production Forecast 2019-2025
        • 9.1.2 Global Sofosbuvir (CAS 1190307-88-0) Production Value Forecast 2019-2025
      • 9.2 Market Forecast by Regions
        • 9.2.1 Global Sofosbuvir (CAS 1190307-88-0) Production and Value Forecast by Regions 2019-2025
        • 9.2.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Regions 2019-2025
      • 9.3 United States
        • 9.3.1 Production and Value Forecast in United States
        • 9.3.2 Consumption Forecast in United States
      • 9.4 European Union
        • 9.4.1 Production and Value Forecast in European Union
        • 9.4.2 Consumption Forecast in European Union
      • 9.5 China
        • 9.5.1 Production and Value Forecast in China
        • 9.5.2 Consumption Forecast in China
      • 9.6 Rest of World
        • 9.6.1 Japan
        • 9.6.2 Korea
        • 9.6.3 India
        • 9.6.4 Southeast Asia
      • 9.7 Forecast by Type
        • 9.7.1 Global Sofosbuvir (CAS 1190307-88-0) Production Forecast by Type
        • 9.7.2 Global Sofosbuvir (CAS 1190307-88-0) Production Value Forecast by Type
      • 9.8 Consumption Forecast by Application

      10 Value Chain and Sales Channels Analysis

      • 10.1 Value Chain Analysis
      • 10.2 Sales Channels Analysis
        • 10.2.1 Sofosbuvir (CAS 1190307-88-0) Sales Channels
        • 10.2.2 Sofosbuvir (CAS 1190307-88-0) Distributors
      • 10.3 Sofosbuvir (CAS 1190307-88-0) Customers

      11 Opportunities & Challenges, Threat and Affecting Factors

      • 11.1 Market Opportunities
      • 11.2 Market Challenges
      • 11.3 Porter's Five Forces Analysis

      12 Key Findings

        13 Appendix

        • 13.1 Research Methodology
          • 13.1.1 Methodology/Research Approach
            • 13.1.1.1 Research Programs/Design
            • 13.1.1.2 Market Size Estimation
            • 13.1.1.3 Market Breakdown and Data Triangulation
          • 13.1.2 Data Source
            • 13.1.2.1 Secondary Sources
            • 13.1.2.2 Primary Sources
        • 13.2 Author Details

        In 2019, the market size of Sofosbuvir (CAS 1190307-88-0) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
        In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sofosbuvir (CAS 1190307-88-0).

        This report studies the global market size of Sofosbuvir (CAS 1190307-88-0), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
        This study presents the Sofosbuvir (CAS 1190307-88-0) production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
        For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

        In global market, the following companies are covered:
        Teva Pharmaceutical Industries Ltd
        DONG BANG FUTURE TECH & LIFE CO., LTD
        NIFTY LABS PVT LTD
        DEAFARMA
        Anhui HaiKang Pharmaceutical Co. Ltd
        Haoyuan Chemexpress Co.Ltd
        SMS Pharmaceuticals Limited
        Beijing Kawin Technology Share-holding Co
        Manus Aktteva Biopharma LLP
        Hangzhou Longshine Bio-Tech Co
        Tecoland
        Sinobright Pharmaceutical Company Limited

        Market Segment by Product Type
        ≥ 98% Purity
        < 98% Purity

        Market Segment by Application
        400mg Tablets
        Others

        Key Regions split in this report: breakdown data for each region.
        United States
        China
        European Union
        Rest of World (Japan, Korea, India and Southeast Asia)

        The study objectives are:
        To analyze and research the Sofosbuvir (CAS 1190307-88-0) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
        To present the key Sofosbuvir (CAS 1190307-88-0) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
        To split the breakdown data by regions, type, companies and applications
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends, drivers, influence factors in global and regions
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

        In this study, the years considered to estimate the market size of Sofosbuvir (CAS 1190307-88-0) are as follows:
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025



        Summary:
        Sofosbuvir (CAS 1190307-88-0) Market Research Report is Sofosbuvir (CAS 1190307-88-0) Market Report. Get Sofosbuvir (CAS 1190307-88-0) market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Sofosbuvir (CAS 1190307-88-0) . Sofosbuvir (CAS 1190307-88-0) Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



        REPORT YOU MIGHT BE INTERESTED